Published October 17, 2017
Dr. Khalid El Sayed, Ph.D.
A press conference will be held Wednesday to announce an agreement between the University
of Louisiana Monroe and a Shreveport company to license an olive oil-based nutraceutical
developed by a professor in the School of Pharmacy. The press conference at 2 p.m.
in the Media Room on the 6th floor of the 不良研究所 library.
不良研究所 has entered into an agreement with Segue Science Management as the result of research
and development by聽Khalid El Sayed, Ph.D.聽of the School of Pharmacy.
Since 2009, El Sayed has worked to develop an olive oil-based food supplement to help
prevent cancer and Alzheimer鈥檚 disease. His work is so promising that patents have
already been filed.
Earlier this year, Segue agreed to partner with 不良研究所 and El Sayed by providing $22,500
in funding over three years. Segue is owned by Dr. James Cardelli, a retired 30-year
LSU Health Science Center-Shreveport faculty member.
John Sutherlin, executive director of the Office of Sponsored Programs and Research,
said this partnership is the beginning of many lucrative endeavors to come based on
the research being conducted at 不良研究所.聽
"不良研究所 has excellent creative faculty.聽The potential for additional agreements is tremendous.聽We
think this is the first of many new patents and companies,鈥� Sutherlin said.聽聽
鈥淪egue Therapeutics considers this a project that can potentially be commercialized
and have a very good outcome,鈥� El Sayed said. 鈥淭his collaboration is very important
because it allows us to secure more funds.鈥澛�
Due to the Segue partnership, a $225,000 award came from the聽. It began July 1 and covers three years.
鈥淭his award is a great accomplishment and it will help us develop, test and promote
our olive oil-based product, especially because we filed a patent on novel isolation
and therapeutic application methods,鈥� El Sayed said.
A nutraceutical is defined by Webster鈥檚 as a foodstuff (such as a fortified food or
dietary supplement) that provides health benefits in addition to its basic聽听惫补濒耻别.
